Where can I find NOV.DE's financial statements?

Novo Nordisk A/S (NOV.DE)'s full income statement, balance sheet, and cash flow statement are on this page in 10-K-style line-item format. Switch between the three statements via the pill toggle above the table.

How much history is available for NOV.DE?

Novo Nordisk A/S (NOV.DE) statements are available back to its earliest filed 10-K — typically 10+ years of annual data and 40 quarters of quarterly data. Free-tier users see 5 years and 8 quarters; full history unlocks with a Pro account.

How often does NOV.DE update its statements?

Novo Nordisk A/S files a 10-K annually (full audited year-end statements) and 10-Q reports quarterly (unaudited interim statements). New filings are typically parsed and reflected on this page within 48 hours of SEC submission.

NOV.DE

Novo Nordisk A/S

XETRA·Drug Manufacturers, General · Healthcare

€39.64€0.93−2.29%

Market cap€176.10B·Market closed·Aug 27 8:56 PM UTC

DKK · values shown as reported

Line item	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025
Revenue	kr 140.80B+10.9%	kr 176.95B+25.7%	kr 232.26B+31.3%	kr 290.40B+25.0%	kr 308.39B+6.2%
Cost of revenue	kr 23.66B+13.0%	kr 28.45B+20.2%	kr 35.77B+25.7%	kr 44.52B+24.5%	kr 58.66B+31.8%
Gross profit	kr 117.14B+10.5%	kr 148.51B+26.8%	kr 196.50B+32.3%	kr 245.88B+25.1%	kr 249.73B+1.6%
Research & development	kr 17.77B+14.9%	kr 24.05B+35.3%	kr 32.44B+34.9%	kr 48.06B+48.1%	kr 51.92B+8.0%
General & administrative	kr 4.05B+2.3%	kr 4.47B+10.3%	kr 4.86B+8.7%	kr 5.28B+8.7%	kr 5.97B+13.1%
Selling & marketing	kr 37.01B+12.4%	kr 46.22B+24.9%	kr 56.74B+22.8%	kr 62.10B+9.4%	kr 64.31B+3.6%
SG&A (combined)	kr 41.06B+11.3%	kr 50.68B+23.4%	kr 61.60B+21.5%	kr 67.38B+9.4%	kr 70.12B+4.1%
Other operating expenses	−kr 332.00M+27.8%	−kr 1.03B−211.4%	−kr 119.00M+88.5%	kr 2.10B+1,867.2%	kr 300.00M−85.7%
Total operating expenses	kr 58.50B+12.7%	kr 73.70B+26.0%	kr 93.92B+27.4%	kr 117.54B+25.1%	kr 122.05B+3.8%
Operating income	kr 58.64B+8.3%	kr 74.81B+27.6%	kr 102.57B+37.1%	kr 128.34B+25.1%	kr 127.68B−0.5%
Interest income	kr 231.00M−31.5%	kr 239.00M+3.5%	kr 1.07B+347.3%	kr 1.84B+71.9%	kr 9.64B+424.4%
Interest expense	kr 289.00M−25.9%	kr 378.00M+30.8%	kr 739.00M+95.5%	kr 1.64B+121.9%	kr 6.76B+312.4%
Other income / (expense), net	kr 436.00M+143.8%	−kr 5.75B−1,418.1%	kr 2.10B+136.5%	−kr 1.15B−154.7%	kr 2.58B+324.4%
Income before tax	kr 59.08B+11.2%	kr 69.06B+16.9%	kr 104.67B+51.6%	kr 127.19B+21.5%	kr 130.25B+2.4%
Income tax expense	kr 11.32B+3.0%	kr 13.54B+19.6%	kr 20.99B+55.1%	kr 26.20B+24.8%	kr 28.04B+7.0%
Net income	kr 47.76B+13.3%	kr 55.53B+16.3%	kr 83.68B+50.7%	kr 100.99B+20.7%	kr 102.21B+1.2%

EPS (basic)	kr 10.40+15.2%	kr 12.26+17.9%	kr 18.62+51.9%	kr 22.67+21.8%	kr 23.01+1.5%
EPS (diluted)	kr 10.37+15.1%	kr 12.22+17.8%	kr 18.62+52.4%	kr 22.63+21.5%	kr 22.98+1.5%
Weighted avg shares (basic)	4,593,200,000	4,530,600,000	4,494,253,000	4,453,900,000	4,443,600,000
Weighted avg shares (diluted)	4,605,304,000	4,544,600,000	4,494,800,000	4,463,000,000	4,449,400,000

Depreciation & amortization	kr 5.31B+0.7%	kr 5.31B−0.1%	kr 9.41B+77.4%	kr 8.55B−9.2%	kr 21.93B+156.7%
EBITDA	kr 64.83B+9.1%	kr 80.88B+24.8%	kr 114.63B+41.7%	kr 137.38B+19.8%	kr 158.95B+15.7%

Frequently Asked Questions About NOV.DE

Where can I find NOV.DE's financial statements?: Novo Nordisk A/S (NOV.DE)'s full income statement, balance sheet, and cash flow statement are on this page in 10-K-style line-item format. Switch between the three statements via the pill toggle above the table.
How much history is available for NOV.DE?: Novo Nordisk A/S (NOV.DE) statements are available back to its earliest filed 10-K — typically 10+ years of annual data and 40 quarters of quarterly data. Free-tier users see 5 years and 8 quarters; full history unlocks with a Pro account.
How often does NOV.DE update its statements?: Novo Nordisk A/S files a 10-K annually (full audited year-end statements) and 10-Q reports quarterly (unaudited interim statements). New filings are typically parsed and reflected on this page within 48 hours of SEC submission.

Line item

FY 2021

FY 2022

FY 2023

FY 2024

FY 2025

Trend

Revenue

kr 140.80B+10.9%

kr 176.95B+25.7%

kr 232.26B+31.3%

kr 290.40B+25.0%

kr 308.39B+6.2%

Cost of revenue

kr 23.66B+13.0%

kr 28.45B+20.2%

kr 35.77B+25.7%

kr 44.52B+24.5%

kr 58.66B+31.8%

Gross profit

kr 117.14B+10.5%

kr 148.51B+26.8%

kr 196.50B+32.3%

kr 245.88B+25.1%

kr 249.73B+1.6%

Research & development

kr 17.77B+14.9%

kr 24.05B+35.3%

kr 32.44B+34.9%

kr 48.06B+48.1%

kr 51.92B+8.0%

General & administrative

kr 4.05B+2.3%

kr 4.47B+10.3%

kr 4.86B+8.7%

kr 5.28B+8.7%

kr 5.97B+13.1%

Selling & marketing

kr 37.01B+12.4%

kr 46.22B+24.9%

kr 56.74B+22.8%

kr 62.10B+9.4%

kr 64.31B+3.6%

SG&A (combined)

kr 41.06B+11.3%

kr 50.68B+23.4%

kr 61.60B+21.5%

kr 67.38B+9.4%

kr 70.12B+4.1%

Other operating expenses

−kr 332.00M+27.8%

−kr 1.03B−211.4%

−kr 119.00M+88.5%

kr 2.10B+1,867.2%

kr 300.00M−85.7%

Total operating expenses

kr 58.50B+12.7%

kr 73.70B+26.0%

kr 93.92B+27.4%

kr 117.54B+25.1%

kr 122.05B+3.8%

Operating income

kr 58.64B+8.3%

kr 74.81B+27.6%

kr 102.57B+37.1%

kr 128.34B+25.1%

kr 127.68B−0.5%

Interest income

kr 231.00M−31.5%

kr 239.00M+3.5%

kr 1.07B+347.3%

kr 1.84B+71.9%

kr 9.64B+424.4%

Interest expense

kr 289.00M−25.9%

kr 378.00M+30.8%

kr 739.00M+95.5%

kr 1.64B+121.9%

kr 6.76B+312.4%

Other income / (expense), net

kr 436.00M+143.8%

−kr 5.75B−1,418.1%

kr 2.10B+136.5%

−kr 1.15B−154.7%

kr 2.58B+324.4%

Income before tax

kr 59.08B+11.2%

kr 69.06B+16.9%

kr 104.67B+51.6%

kr 127.19B+21.5%

kr 130.25B+2.4%

Income tax expense

kr 11.32B+3.0%

kr 13.54B+19.6%

kr 20.99B+55.1%

kr 26.20B+24.8%

kr 28.04B+7.0%

Net income

kr 47.76B+13.3%

kr 55.53B+16.3%

kr 83.68B+50.7%

kr 100.99B+20.7%

kr 102.21B+1.2%

EPS (basic)

kr 10.40+15.2%

kr 12.26+17.9%

kr 18.62+51.9%

kr 22.67+21.8%

kr 23.01+1.5%

EPS (diluted)

kr 10.37+15.1%

kr 12.22+17.8%

kr 18.62+52.4%

kr 22.63+21.5%

kr 22.98+1.5%

Weighted avg shares (basic)

4,593,200,000

4,530,600,000

4,494,253,000

4,453,900,000

4,443,600,000

Weighted avg shares (diluted)

4,605,304,000

4,544,600,000

4,494,800,000

4,463,000,000

4,449,400,000

Depreciation & amortization

kr 5.31B+0.7%

kr 5.31B−0.1%

kr 9.41B+77.4%

kr 8.55B−9.2%

kr 21.93B+156.7%

EBITDA

kr 64.83B+9.1%

kr 80.88B+24.8%

kr 114.63B+41.7%

kr 137.38B+19.8%

kr 158.95B+15.7%